Skip to main content

Find Clinical Trials

Home
Conditions
Newly Diagnosed High-Risk Cytogenetic Multiple Myeloma Patients Ineligible or Unwilling to Undergo ASCT

Clinical trial condition

Newly Diagnosed High-Risk Cytogenetic Multiple Myeloma Patients Ineligible or Unwilling to Undergo ASCT

Explore clinical trials studying Newly Diagnosed High-Risk Cytogenetic Multiple Myeloma Patients Ineligible or Unwilling to Undergo ASCT. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Newly Diagnosed High-Risk Cytogenetic Multiple Myeloma Patients Ineligible or Unwilling to Undergo ASCT trial results

Not Yet Recruiting

RN1201 Injection in Newly Diagnosed High-Risk Cytogenetic Multiple Myeloma

NCT07114432

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: Tianjin Medical University Cancer Institute and Hospital Tianjin, Tianjin Municipality, China

Tianjin Cancer Hospital Airport Hospital Tianjin, Tianjin Municipality, China

View Trial Details